$1.8 Million To Improve Vaccine Strategies For P. Carinii Pneumonia Awarded To LSUHSC's Kolls

Main Category: Infectious Diseases / Bacteria / Viruses
Also Included In: Respiratory / Asthma;  Transplants / Organ Donations;  Immune System / Vaccines
Article Date: 09 Jul 2009 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:not yet rated


Jay K. Kolls, MD, Professor and Chairman of Genetics at LSU Health Sciences Center New Orleans School of Medicine, has been awarded $1.8 million over five years by the National Heart, Lung and Blood Institute of the National Institutes of Health to study whether antibodies that recognize carbohydrate (sugars) and proteins on the surface of the fungus that causes Pneumocystis carinii pneumonia (PCP) can be used to prevent the infection.

Pneumocystis carinii pneumonia remains a serious complication in patients with weakened immune systems, such as those with AIDS, cancer, chronic conditions treated with corticosteroids, or organ transplant recipients.

Earlier research by Dr. Kolls found that carbohydrate antibodies are part of the natural response to the Pneumocystis fungus. Theses preliminary studies show that these antibodies participate in early clearance of the organism from the lung as well as regulate long term immune responses to the organism. The research team believes that this response might be harnessed to develop a vaccine to prevent or better treat infections from this fungus.

This funding will advance the research seeking not only to confirm that anti-carbohydrate antibodies are part of the natural response repertoire to the Pneumocystis fungus, but also that when combined with a potent protein antigen called Kex1, these antibodies can regulate direct killing of the fungus and confer immunity.

"Understanding these antibody responses will improve vaccine strategies for this human infection," notes Dr. Jay Kolls, who is also the principal investigator on the grant.

Source:
Leslie Capo
Louisiana State University Health Sciences Center

Article adapted by Medical News Today from original press release.
Visit our infectious diseases / bacteria / viruses section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Leslie Capo. "$1.8 Million To Improve Vaccine Strategies For P. Carinii Pneumonia Awarded To LSUHSC's Kolls." Medical News Today. MediLexicon, Intl., 9 Jul. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/156825.php>

APA
Leslie Capo. (2009, July 9). "$1.8 Million To Improve Vaccine Strategies For P. Carinii Pneumonia Awarded To LSUHSC's Kolls." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/156825.php.

Please note: If no author information is provided, the source is cited instead.


Infectious Diseases / Bacteria / Viruses

Most Popular Articles



Follow Our Infectious Diseases News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Infectious Diseases / Bacteria / Viruses Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »